logo-loader
viewIntegumen

Integumen PLC to test anti-viral skin and dental products through tie-up with University of Aberdeen

Integumen PLC's (LON:SKIN) Gerry Brandon caught up with Proactive London's Andrew Scott after announcing its subsidiary Labskin has partnered with the University of Aberdeen to test anti-viral skin and dental products that might mitigate the transmission risk of the coronavirus (COVID-19).

Scientists will use Labskin’s cloned human skin coated with the SARS-CoV-2 virus in their research which will take place in a Category 3 lab at the university.

Quick facts: Integumen

Price: 1.925 GBX

AIM:SKIN
Market: AIM
Market Cap: £20.77 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Integumen named herein, including the promotion by the Company of Integumen in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Integumen's Gerry Brandon outlines collaboration with Avacta for real-time...

Integumen PLC's (LON:SKIN) Gerry Brandon caught up with Proactive London's Andrew Scott after announcing a collaboration with Avacta PLC (LON:AVCT) to use their technology in a coronavirus (COVID-19) detection kit. He says they've signed a material transfer agreement to use recently-generated...

20 hours, 40 minutes ago

2 min read